InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-12.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by STEINMAN LAWRENCE, Director. Insider active across 3 companies, notably BioAtla, Inc.. In total, 27 reports have been logged. Breakdown: 5 buys · 8 sells. Total volume traded: €219k. Activity tracked since 14 June 2021. The latest transaction was disclosed on 20 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations27 total
65,000 shares0Common StockSEC:0001213900-25-016193:0
16,500 shares0Common StockSEC:0000950170-24-073675:0
20,000 shares@ US$2.052425.2% of flowCommon StockSEC:0001209191-23-059284:0
Ideal exit: 14 Sept 2024 (T+270)
30,000 shares@ US$0.43128.3% of flowCommon StockSEC:0001493152-23-020333:0
Ideal exit: 27 Feb 2024 (T+270)
18,000 shares@ US$1.22618.3% of flowCommon StockSEC:0001213900-23-045386:0
Ideal exit: 26 Feb 2024 (T+270)
5,000 shares@ US$0.9811.1% of flowCommon StockSEC:0001213900-22-075491:0
5,000 shares@ US$0.9911.4% of flowCommon StockSEC:0001213900-22-074585:0
5,000 shares@ US$1.1012.8% of flowCommon StockSEC:0001213900-22-066554:0
1,000 shares@ US$1.142.7% of flowCommon StockSEC:0001213900-22-064401:0
5,000 shares@ US$1.0250.5% of flowCommon StockSEC:0001213900-22-036296:0
5,000 shares@ US$1.0011.1% of flowCommon StockSEC:0001213900-22-035201:0
5,000 shares@ US$1.0049.5% of flowCommon StockSEC:0001213900-22-034621:0
652,174 shares0Common StockSEC:0001213900-22-034366:0
5,000 shares@ US$4.2716.8% of flowCommon StockSEC:0001213900-21-064570
Ideal exit: 5 Sept 2022 (T+270)
5,000 shares@ US$4.2720.5% of flowCommon StockSEC:0001213900-21-064570:0
Ideal exit: 5 Sept 2022 (T+270)
450 shares@ US$30.000.16% mcap10.4% of flowCommon StockSEC:0001209191-21-062747:0
450 shares@ US$30.007.8% of flowCommon StockSEC:0001209191-21-062747
5,216 shares@ US$6.0024.1% of flowCommon StockSEC:0001013762-21-000203
5,216 shares@ US$6.0029.5% of flowCommon StockSEC:0001013762-21-000203:0
450 shares@ US$36.820.20% mcap12.6% of flowCommon StockSEC:0001209191-21-056574:0
450 shares@ US$36.829.4% of flowCommon StockSEC:0001209191-21-056574
450 shares@ US$40.600.22% mcap13.9% of flowCommon StockSEC:0001209191-21-052295:0
450 shares@ US$40.6010.4% of flowCommon StockSEC:0001209191-21-052295
450 shares@ US$38.299.8% of flowCommon StockSEC:0001209191-21-047324
450 shares@ US$38.290.21% mcap13.1% of flowCommon StockSEC:0001209191-21-047324:0
25 of 27 declarations
About STEINMAN LAWRENCE
Lawrence Steinman is an executive at BioAtla, Inc.
